HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-145 Cr | ₹-137 Cr | ₹-174 Cr | ₹-292 Cr | ₹-284 Cr |
What is the latest Cash Flow from Investing Activities ratio of HIKAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-145 Cr |
| Mar2025 | ₹-137 Cr |
| Mar2024 | ₹-174 Cr |
| Mar2023 | ₹-292 Cr |
| Mar2022 | ₹-284 Cr |
How is Cash Flow from Investing Activities of HIKAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-145 Cr | Negative | |
| Mar2025 | ₹-137 Cr | Negative | |
| Mar2024 | ₹-174 Cr | Negative | |
| Mar2023 | ₹-292 Cr | Negative | |
| Mar2022 | ₹-284 Cr | - | |
Compare Cash Flow from Investing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,673.1 Cr | 1.7% | -3.8% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 1.7% |
-3.8% |
-10.2% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses